Results 41 to 50 of about 1,905,123 (363)

Adjuvant therapy for early uterine high-grade leiomyosarcoma [PDF]

, 2019
TO THE EDITOR: The article by Hensley et al1 recently published in Journal of Clinical Oncology was interesting, even if apparently negative (Gynecology Oncology Group [GOG]-0277 randomized phase III trial). The study investigated the activity and safety
Panici, P. B., Tomao, F., Tomao, S.
core   +1 more source

World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology

Frontiers in Oncology, 2021
Significant advances in our understanding of the molecular genetics of pediatric and adult brain tumors and the resulting rapid expansion of clinical molecular neuropathology have led to improvements in diagnostic accuracy and identified new targets for ...
Erik P. Sulman, Erik P. Sulman, Erik P. Sulman, Erik P. Sulman, David D. Eisenstat, David D. Eisenstat, David D. Eisenstat, David D. Eisenstat   +7 more
doaj   +1 more source

Exploring the Capabilities and Limitations of Large Language Models for Radiation Oncology Decision Support [PDF]

International Journal of Radiation Oncology, Biology, Physics. 2024 Mar 15;118(4):900-4
Thanks to the rapidly evolving integration of LLMs into decision-support tools, a significant transformation is happening across large-scale systems. Like other medical fields, the use of LLMs such as GPT-4 is gaining increasing interest in radiation oncology as well.
arxiv   +1 more source

The Sir Anthony Mamo Oncology Centre [PDF]

, 2015
In 2009, the development of a medical brief, effectively detailing the specifications for a purpose-built oncology hospital and including the medical equipment and human resources required, was commenced. Robust engagement by the relevant stakeholders,
Laspina, Stefan
core  

The dual nature of TDC – bridging dendritic and T cells in immunity

FEBS Letters, EarlyView.
TDC are hematopoietic cells combining dendritic and T cell features. They reach secondary lymphoid organs (SLOs) and peripheral organs (liver and lungs) after FLT3‐dependent development in the bone marrow and maturation in the thymus. TDC are activated and enriched in SLOs upon viral infection, suggesting that they might play unique immune roles, since
Maria Nelli, Mirela Kuka
wiley   +1 more source

Validation of claims algorithms for progression to metastatic cancer in patients with breast, non-small cell lung, and colorectal cancer

Frontiers in Oncology, 2016
Background: Validated algorithms for identifying progression to metastatic cancer could permit the use of administrative claims databases for research in this area.Objective: To identify simple algorithms that could accurately detect cancer progression ...
Beth L. Nordstrom, Jason C. Simeone, Karen G. Malley, Kathy H. Fraeman, Zandra eKlippel, Mark eDurst, John H. Page, Hairong eXu   +7 more
doaj   +1 more source

Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients [PDF]

, 2016
There is a paucity of data to support evidence-based practices in the provision of patient/family education in the context of a new childhood cancer diagnosis.
Ahern, JoAnn, Barakat, Lamia P., Bhatia, Smita, Bingen, Kristin M., Bondurant, Patricia G., Cohn, Susan L., Dobrozsi, Sarah K., Haugen, Maureen, Herring, Ruth Anne, Hockenberry, Marilyn, Hooke, Mary C., Landier, Wendy, Martin, Melissa, Murphy, Kathryn, Newman, Amy R., Rodgers, Cheryl C., Ruccione, Kathleen S., Sullivan, Jeneane, Weiss, Marianne E., Withycombe, Janice, Yasui, Lise   +20 more
core   +1 more source

Magnons in Ferromagnetic Metallic Manganites [PDF]

, 2007
Ferromagnetic (FM) manganites, a group of likely half-metallic oxides, are of special interest not only because they are a testing ground of the classical doubleexchange interaction mechanism for the colossal magnetoresistance, but also because they ...
Dai, Pengcheng, Fernandez-Baca, J. A., Plummer, E. W., Sha, Hao, Ye, F., Zhang, Jiandi   +5 more
core   +1 more source

FoxO1 signaling in B cell malignancies and its therapeutic targeting

FEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac, Petra Pavelkova, Laura Ondrisova, Marek Mraz   +3 more
wiley   +1 more source

The road to precision oncology [PDF]

, 2017
The ultimate goal of precision medicine is to use population-based molecular, clinical and other data to make individually tailored clinical decisions for patients, although the path to achieving this goal is not entirely clear.
Andrew V Biankin, FS Collins, M Gerstung, V Marx   +3 more
core   +1 more source